142 related articles for article (PubMed ID: 8891736)
21. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
22. The association between murine beta 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains.
Ferrier P; Layet C; Caillol DH; Jordan BR; Lemonnier FA
J Immunol; 1985 Aug; 135(2):1281-7. PubMed ID: 2409144
[TBL] [Abstract][Full Text] [Related]
23. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
24. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
25. Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice.
Carmon L; Bobilev-Priel I; Brenner B; Bobilev D; Paz A; Bar-Haim E; Tirosh B; Klein T; Fridkin M; Lemonnier F; Tzehoval E; Eisenbach L
J Clin Invest; 2002 Aug; 110(4):453-62. PubMed ID: 12189239
[TBL] [Abstract][Full Text] [Related]
26. Serological and structural analysis of HLA class I molecules: beta 2-microglobulin interacts with the two external domains of the HLA class I heavy chain.
Ferrier P; Kahn-Perles B; Layet C; Pontarotti P; Sire J; Hakem R; Le Bouteiller P; Toubert A; Perarnau B; Roudier J
Ann Inst Pasteur Immunol; 1987; 138(1):19-35. PubMed ID: 2437937
[TBL] [Abstract][Full Text] [Related]
27. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
Wintzer HO; Benzing M; von Kleist S
Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
[TBL] [Abstract][Full Text] [Related]
28. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
29. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
30. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
[TBL] [Abstract][Full Text] [Related]
31. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
[TBL] [Abstract][Full Text] [Related]
32. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
[TBL] [Abstract][Full Text] [Related]
33. Antigenic determinants shared between HLA-A, -B, -C antigens and H-2 class I molecules modified by bovine beta-2 microglobulin.
Mierau R; Robinson PJ; Sanderson AR; Genth E; Cramer M
Immunogenetics; 1987; 26(6):351-5. PubMed ID: 2444534
[TBL] [Abstract][Full Text] [Related]
34. Loss of polymorphic A and B locus HLA antigens in colon carcinoma.
Rees RC; Buckle AM; Gelsthorpe K; James V; Potter CW; Rogers K; Jacob G
Br J Cancer; 1988 Apr; 57(4):374-7. PubMed ID: 3291922
[TBL] [Abstract][Full Text] [Related]
35. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
36. Expression of HLA class I heavy chains and beta 2-microglobulin does not affect human cytomegalovirus infectivity.
Beersma MF; Wertheim-van Dillen PM; Geelen JL; Feltkamp TE
J Gen Virol; 1991 Nov; 72 ( Pt 11)():2757-64. PubMed ID: 1658201
[TBL] [Abstract][Full Text] [Related]
37. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.
Natali PG; Nicotra MR; Bigotti A; Venturo I; Marcenaro L; Giacomini P; Russo C
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6719-23. PubMed ID: 2672003
[TBL] [Abstract][Full Text] [Related]
38. Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer.
Kaklamanis L; Gatter KC; Hill AB; Mortensen N; Harris AL; Krausa P; McMichael A; Bodmer JG; Bodmer WF
Int J Cancer; 1992 May; 51(3):379-85. PubMed ID: 1592528
[TBL] [Abstract][Full Text] [Related]
39. Role of HLA class I and class II antigens in activation and differentiation of B cells.
Giudizi MG; Biagiotti R; Almerigogna F; Alessi A; Tiri A; Del Prete GF; Ferrone S; Romagnani S
Cell Immunol; 1987 Aug; 108(1):97-108. PubMed ID: 3111726
[TBL] [Abstract][Full Text] [Related]
40. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
McEvoy CR; Seshadri R; Morley AA; Firgaira FA
Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
